Pinnacle Medicines is a biotechnology company focused on developing a new generation of oral peptide therapeutics designed to deliver biologic-level efficacy with the convenience of oral dosing. The company is building a differentiated discovery platform that integrates physics-based molecular simulations, artificial intelligence - enabled design, and advanced peptide chemistry to rationally design and optimize peptide medicines. Pinnacle is advancing a pipeline of potential first- and best-in-class oral peptide programs targeting validated pathways in immunology and cardiometabolic diseases.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/26/26	$89,000,000	Series B	Foresite Capital HanKang Capital LAV Fund Logos Capital OrbiMed Advisors Quan Capital RA Capital Management	undisclosed